« Back to the previous page

Also available in: Deutsch Nederlands Français

Pharmaceutical tablet manufacturer wanted in Europe

Company to buy 

  • Size: small to large-sized business
  • Revenue: 3M –30M EUR
  • Preferred location of the target company: EU
  • Reason for acquisition: The management is keen to set a footprint in Central and Western Europe
  • #CFIE PHB005

Overview of the pharmaceutical tablet manufacturer wanted in Europe 

The management of a European pharma and biotech company has decided to expand the presence in European Union region via acquisitions. The buyer company is among ten largest pharmaceutical companies in the region and is one of the top rated. The company has now decided to expand its footprint via M&A activities.

Profile (strategy) of the buyer for pharmaceutical tablet manufacturer buyer

The buyer is a pharmaceutical and biotechnology company, based in EU, manufacturing over 250 products offered to patients around the world. The products are marketed in nearly 60 countries in Europe, including Middle East, Asia, Africa, Latin America and Australia. Affiliates and representative offices are established already in more than 5 countries of Europe. The company has over 30 years of a history of profitable growth in European markets as well as a successful track record in developing license-out business. 
The company is focused on multiple therapeutic areas, including cardiology, oncology, pulmonology, dermatology, gynaecology, urology, ophthalmology, angiology, psychiatry, allergology, gastroenterology, rheumatology, etc.
The buyer company focuses strongly on research and development, owning over 90 patents in generic and innovative products. The company has scientific research partnerships with leading universities and institutes, over 150 scientists collaborating with the buyer on the research of effective therapies.
The company has a history of more than 30 years, successfully growing until today, with two production facilities in Europe. The company had acquired multiple targets in last 10 years in the pharma sector. The production facilities have cGMP certifications and implemented methods like Kaizen, TMP / SPED etc.s
The buyer has a revenue of more than 150M EUR, constantly growing by >5% per year.

Contact this buyer
of pharma companies

Get informed about this potential buyer of your company

Activities and products of the pharmaceutical tablet manufacturer target wanted 

The target should be a tablet manufacturing facility or operate in similar production. The buyer requires the target to have GMP standard and all other necessary licenses and certifications.
It is also preferred for the target to be active in following markets (but not compulsory):
  • Italy
  • Germany
  • Spain
The management is, however, open to receive investment opportunities from all countries of Europe, in all sizes.

Highlights of the pharmaceutical tablet manufacturer wanted in Europe

  • The buyer is a large pharma and biotech company, successfully growing and wanting to expand its footprint by M&A
  • The company is looking for suitable targets in countries of Europe, specialized in tablet manufacturing or similar
  • The buyer can bring various synergies to the target

Information of the pharmaceutical tablet manufacturer wanted in Europe

Feel free to contact us for more information regarding this tablet manufacturer wanted in Europe or if you know possible interested or suited parties. For more buyers of pharmaceutical companies please visit the section pharmaceutical companies wanted. For pharmaceutical companies for sale visit the section pharmaceutical companies for sale. If you have other intentions in the pharma sector, reach out to us – we know the pharmaceutical M&A market and we are ready to help you.